News

SPINEART has announced the 510k approval of their ROMEO® MIS lumbar minimally invasive system by the FDA in the United States. The system is designed to allow for minimally invasive as well as open surgery. It will also feature the possibilities of a percutaneous surgery, spondylolysthesis and fracture reduction.

SPINEART is proud to announce, that its spectacular progression in France continued with an amazing 39% revenue increase over 2008.
Based on the revenues generated and the official Millennium Research European market study, spineart has conquered 29% of the cervical disc replacement market in France, 15,6% of the intervertebral segment (PLIF, TLIF, ALIF, ACIF, type JULIET® and TRYPTIK® cages) and 10,6% of the thoraco-lumbar DDD segment (Osteosynthesis screws and fixations type ROMEO®).

SPINEART is proud to announce that since the first implantation in January 2007, their cervical disc prosthesis BAGUERA®C has successfully been implanted more than 3.000 times worldwide with very satisfying results. BAGUERA®C is the world’s first MRI compatible, pre-assembled, anatomical cervical artificial disc, designed to absorb shocks while containing a guided mobile PE inlay.

Spineart has announced the opening of the Italian market by signing with the MBA group. MBA is a medical device marketing and distribution organization and specializes in the sale of products used for treatment of the spine. MBA is the largest private independent distributor of orthopedic devices in Europe, generating more than $100 million in total sales in 2008.

Spineart is proud to announce that their cervical disc prosthesis BAGUERA®C has successfully been implanted more than 2.300 times worldwide within the last 2 1/2 years with very satisfying results. BAGUERA®C is the world’s first MRI compatible, pre-assembled, and shock absorbing cervical artificial disc containing a guided mobile PE inlay.

Spineart has announced the 510k approval for their TRYPTIK® CA cervical interbody cage. The cage follows Spineart’s unique load sharing concept, which is designed to accelerate and improve the fusion process. To date the TRYPTIK®CA cervical cage has been implanted over 5.000 times worldwide.